Search

everythinglearnresearchcommunity

for

Search:↓

Cyproterone acetate is a safe treatment that causes modest feminization in transgender female adolescents, and works better with added estrogens.

Testosterone treatment may affect heart response to stress in transgender men.

Testosterone creams and gels can be effective but have serious risks and should be used only with medical supervision.

Australian doctors experienced in adult transgender healthcare mostly prescribe intramuscular testosterone and oral estradiol, recommend mental health assessments before hormone therapy, and support improved training and guidelines.

A woman's high testosterone and related symptoms were caused by overactive cells in her ovaries.

Testosterone therapy and surgeries like mastectomy improve transgender men's lives and mental health with low risks and high satisfaction.

Testosterone undecanoate safely and effectively increased penis size in male children with 5-alpha-reductase deficiency.

Short-term testosterone therapy in women seems safe with few mild side effects, but long-term effects need more research.

ADT-G may be a useful indicator of increased androgen levels in women with acne and can be lowered with certain birth control pills.

The niosomal gel effectively delivers testosterone through the skin with fewer side effects.

Testosterone and finasteride improve body composition in men with spinal cord injury.

Male pattern baldness may indicate arterial stiffness in transgender men on long-term testosterone therapy.

Testosterone injections can cause skin darkening and thickening.

The combination of cyproterone acetate and testosterone enanthate is highly effective in preventing sperm production and could be a good reversible male contraceptive.

Transgender females can reach their target estrogen levels using estradiol patches, especially if oral treatments fail or if they're at risk for blood clots. Often, the highest dose patch is needed.

Testosterone therapy may help women with low sexual desire after surgical menopause.

A woman's mature cystic teratoma caused her virilization by producing testosterone.

An ovarian tumor caused a woman's male-like symptoms, which improved after surgery.

Some antiandrogens may lower testosterone better than others, but it's unclear which is best for feminization in transgender women; more research is needed.

The combination treatment reduced prostate size and improved testosterone deficiency symptoms but was less effective for sexual function.

Testosterone therapy can improve sexual desire and function in postmenopausal women but should be used cautiously and not based solely on testosterone levels.

Finasteride delivery through skin improved using invasomes and iontophoresis.

The normal human prostate does not significantly affect blood DHT levels.

Hormone therapy in transgender individuals can increase acne and affect hair growth and loss.

Cyproterone acetate treatment is safe and causes mild feminization, which increases with added estrogen.

A 71-year-old woman developed male-like features due to high testosterone levels caused by a benign ovarian tumor, which was successfully removed by surgery.

Testosterone replacement can help menopausal women with various symptoms, but should be used carefully and is not yet officially licensed in the UK for women.

New treatments for low male hormones improved sexual function and mood but had unclear risks, especially for older men.

Spironolactone treatment increases the amount of testosterone available in the body.